Novel neurosurgical device for evacuation of intracerebral hematoma
Active Project Grant Awarded Last action
- Award ID
- R01NS143100
- Recipient
-
Beckman Research Institute Of The City Of Hope UEI NPH1VN32EWN5
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,072,800
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date 27% complete
- Place of performance
- Irwindale, CA 91010, USA
Award details come from USAspending.gov.
Description
- Abstract
- Spontaneous supratentorial intracerebral hemorrhage (ICH) affects nearly 67,000 patients every year in the US and is associated with a 35-50% mortality rate within a month of occurrence. In addition to preventive measures and medical management, surgery continues to be an important part of treatment for such patients. Currently, removal of ICH from the brain is accomplished through a craniotomy, or large skull opening. For most large hematomas that come to the surface of the brain, this technique is effective in providing adequate surgical exposure to remove the mass and to obtain hemostasis. A craniotomy, however, is time consuming and retraction of the brain during these operations can result in brain injury. Furthermore, large craniotomies can contribute to postoperative morbidity, such as pain and wound-related complications. Development of less invasive techniques and methodology will minimize these risks and patient discomfort. Moreover, minimally invasive techniques may have socio-economic value by reducing operative and postoperative recovery time, especially for an elderly patient population with multiple medical CO-morbidities. Current minimally invasive technologies, however, result in variable ICH evacuation rates and have limited efficacy in removing deeply located basal ganglia hematomas. Thus, neurosurgical devices that enable rapid and consistent hematoma evacuation, irrespective of ICH location, are needed. The goal of this project is to fabricate and determine the feasibility of a novel instrument (termed "remide") that can efficiently and consistently remove an ICH using image-guided, minimally invasive techniques. Our initial studies using proof-of-concept prototypes that we designed and fabricated have demonstrated the feasibility of the approach. Our robotic device creates a cavity in the brain through a
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $633,561 | |
| Original award | $439,239 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Loma Linda University | $249,551 | |
| The Regents Of The University Of California | $528,819 |
Quick answers
Who received award R01NS143100?
R01NS143100 was awarded to Beckman Research Institute Of The City Of Hope by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on July 1, 2025.
How much is award R01NS143100 worth?
$1,072,800 has been obligated on R01NS143100.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award